The present study demonstrated that RPL6 and cyclin E expressions in human gastric cancer specimens were relative (Fig. 1B, p<0.05), which may play a con-generous role in the development of gastric cancer and RPL6 and cyclin E may serve as a biomarker for gastric cancer diagnosis and a gene target for gastric cancer therapy. This evidence concerns the gene RPL6 and gastric cancer.